Oct. 15, 2018 /CNW/ - Pivot Pharmaceuticals Inc. (CSE: PVOT / OTCQB: PVOTF / FRA: NPAT) ("Pivot") and Knol Resources Corp. (TSX-V: NOL.H) ("Knol") are pleased to announce the execution of a Letter of Intent for the Reverse Takeover of Knol pursuant to which Pivot will spin out to Knol its non-U.S. cannabis assets, thereby unlocking the underlying value of Pivot's global assets (the "Spin Out Transaction" or the "Transaction").
Read more
Pivot Pharmaceuticals Inc. to Spin Out Non-U.S. Assets to Unlock Shareholder Value
